Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| AstraZeneca | 8.73% | $83.95M | £208.42B | 28.43% | 80 Outperform | |
| HSBC Holdings | 8.37% | $80.55M | HK$1.99T | 45.10% | 80 Outperform | |
| Shell (UK) | 6.84% | $65.80M | £153.44B | 7.52% | 73 Outperform | |
| Unilever | 4.49% | $43.20M | £105.45B | -7.82% | 72 Outperform | |
| Rolls-Royce Holdings | 4.03% | $38.74M | £92.13B | 102.63% | 71 Outperform | |
| British American Tobacco | 3.68% | $35.37M | £92.11B | 41.64% | 71 Outperform | |
| GlaxoSmithKline | 3.20% | $30.74M | £73.63B | 37.23% | 77 Outperform | |
| BP p.l.c. | 3.03% | $29.16M | £67.22B | 10.94% | 71 Outperform | |
| Barclays | 2.71% | $26.11M | £61.63B | 64.94% | 78 Outperform | |
| Rio Tinto | 2.50% | $24.06M | £96.55B | 14.06% | 82 Outperform |